Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Some drugs can cause changes to your hair.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.